Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.
about
Vaccines for preventing rotavirus diarrhoea: vaccines in useVaccines for preventing rotavirus diarrhoea: vaccines in useCombined and alternating paracetamol and ibuprofen therapy for fever in childrenVaccines for preventing rotavirus diarrhoea: vaccines in useSafety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and LessonsPharmacological and Combined Interventions to Reduce Vaccine Injection Pain in Children and Adults: Systematic Review and Meta-AnalysisFever: Views in Anthroposophic Medicine and Their Scientific ValidityPossible immunosuppressive effects of drug exposure and environmental and nutritional effects on infection and vaccinationA Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine ModelAnalgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunityLow-dose aspirin use does not diminish the immune response to monovalent H1N1 influenza vaccine in older adultsParacetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunityImpact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study.Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline.Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials.Perception and management of fever in infants up to six months of age: a survey of US pediatricansA randomized placebo-controlled trial of acetaminophen for prevention of post-vaccination fever in infants.Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life.Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial.Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood Phase Three.Vaccination in elite athletes.A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study.Who's afraid of fever?Prophylactic antipyretics for prevention of febrile seizures following vaccinationAn open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, aNeutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trialOptimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling.The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review.Clinical review: fever in septic ICU patients--friend or foe?Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination.Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets.Infant sleep after immunization: randomized controlled trial of prophylactic acetaminophen.A literature review on the patients with autoimmune diseases following vaccination against infections.Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain ManagementEarly antipyretic exposure does not increase mortality in patients with gram-negative severe sepsis: a retrospective cohort study.Prospects for eradication of meningococcal diseaseClinical and demographic factors associated with antipyretic use in gram-negative severe sepsis and septic shock.Effects of Administering Prophylactic Acetaminophen on Short-term Complications of Vaccination in 6-month-old Infants.Randomized controlled trial of the effect of regular paracetamol on influenza infection
P2860
Q24197495-CB8131FE-5CA3-4D2F-959C-9BFEA2395D89Q24203645-7C170254-F23D-4EE9-94FF-2ED59492530EQ24203969-2FF13ABC-75E2-464A-BAD7-B89C9C22D5A3Q24235411-54F63833-EACA-45E2-B926-02ADB50AF8C1Q26778259-18A4DD76-FB55-40E7-8B4B-FC5B070850CAQ26800959-84B9F273-805E-410B-931C-974B98ACAF4CQ28072346-4BCDCE7C-4B4C-40BD-B4F4-238DB366F747Q28083673-B57F16A9-7928-4B83-9710-AA18BB73ECB9Q28551334-F0FE00F7-1BCD-487E-A1E3-BCE6E8130A1EQ30352664-142FE478-A937-4888-A103-2CA4A4A64D1CQ30378668-4489E187-8D1B-4DB1-8B44-00394D850388Q30399547-1C06699A-96D5-4A63-9AB2-D56DB6D1521DQ30400508-8939F105-2B94-40E6-B401-61A9C51A29A1Q30497652-24D45C9A-BDBC-4510-BF36-23F77D5440DCQ33711931-8B5E849E-D3AB-4F66-B43C-903F2FA5A232Q33777519-15DBC2F8-EDC3-4296-AE37-322BB68AFE2CQ33940618-E7B114E7-75AA-4DD4-A818-92E196215817Q34033855-C3026277-23A4-4399-AE63-706CE8C026F0Q34082225-D114C9A7-116D-4A4B-A657-3586A1F494D2Q34131235-3BD1CE13-05B5-414A-B934-3D76DA371B38Q34227424-BF663738-2969-428B-B725-8E3C787B97E4Q34291176-F66F2867-8F8D-49B5-8D43-9D852C2BBEC0Q34316082-F0BF6C95-33E5-43F3-BA98-51289F57E3D6Q34476521-17975D51-822A-41E5-8098-745875CA7030Q34551442-5E954796-CE84-4CB9-82CB-2BE793393274Q34779453-8BFEC07C-2AE0-4DCD-A23D-609722ECA1D1Q34948025-50271338-4E61-489D-9DD4-94257C57F146Q35138184-57A933CE-42AD-420A-8C7D-42D01B8BB29DQ35236644-47BAD12F-400E-424D-981E-B5ADF09E6171Q35558149-B202CA67-FEA5-4EF3-AA4A-05A8B4E06D2DQ35744127-DFDAD2E1-2E54-4E93-892A-39036DC395BEQ35994233-13C9FF23-9D0F-4029-BD46-A31571E92C7CQ36071189-D935FD10-9ABE-4D30-AE32-CD049FA71949Q36255747-52685AF3-E070-40AD-8F03-76204802E0A8Q36365813-9B26BC00-1252-4DD2-92C6-D5D42591D9E8Q36435051-FF3FBEEE-F49F-4F57-ADE2-9B56E7062EA4Q36440358-5EAAEC0F-5290-4164-B272-E51CF17313D5Q36455088-58064DFC-8681-4505-8D93-9F160D7C1889Q36529323-09A2A2F5-E371-4DF8-B285-8E1E7EA5D701Q36536803-4FE30FD2-2D06-428C-81A0-16D459B31109
P2860
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effect of prophylactic paracet ...... randomised controlled trials.
@ast
Effect of prophylactic paracet ...... randomised controlled trials.
@en
Effect of prophylactic paracet ...... randomised controlled trials.
@nl
type
label
Effect of prophylactic paracet ...... randomised controlled trials.
@ast
Effect of prophylactic paracet ...... randomised controlled trials.
@en
Effect of prophylactic paracet ...... randomised controlled trials.
@nl
prefLabel
Effect of prophylactic paracet ...... randomised controlled trials.
@ast
Effect of prophylactic paracet ...... randomised controlled trials.
@en
Effect of prophylactic paracet ...... randomised controlled trials.
@nl
P2093
P50
P1433
P1476
Effect of prophylactic paracet ...... , randomised controlled trials
@en
P2093
Dorota Borys
Eva Kaliskova
Helena Zemlickova
Lode Schuerman
Marie Vackova
Patricia Lommel
Roman Chlibek
P304
P356
10.1016/S0140-6736(09)61208-3
P407
P577
2009-10-01T00:00:00Z